Plea for multitargeted interventions for severe COVID-19

Affiliations

¹ Department of Infectious Diseases, Hotel-Dieu Hospital and INSERM CIC 1413, Nantes University Hospital, Nantes 44093, France.
² Internal Medicine Department, Lariboisière Hospital, Paris, France.
³ Clinic of Infectious Diseases, University of Modena and Reggio Emilia, Modena, Italy.
⁴ Infectious Diseases Unit, Internal Medicine Service, Hospital La Paz, IdiPAZ, Madrid, Spain.
⁵ Department for Clinical Immunology and Rheumatology, Hannover Medical School, Hannover, Germany.
⁶ Toronto General Hospital Research Institute, Toronto, ON, Canada.
⁷ Chelsea and Westminster Hospital NHS Foundation Trust and London School of Hygiene & Tropical Medicine, London, UK.
⁸ Department of Infectious Diseases, Hotel-Dieu Hospital and INSERM CIC 1413, Nantes University Hospital, Nantes 44093, France. Electronic address: francois.raffi@wanadoo.fr.

Benjamin Jean Gaborit et al. Lancet Infect Dis. 2020 Oct.

. 2020 Oct;20(10):1122-1123.

doi: 10.1016/S1473-3099(20)30312-1. Epub 2020 Apr 21.

¹ Department of Infectious Diseases, Hotel-Dieu Hospital and INSERM CIC 1413, Nantes University Hospital, Nantes 44093, France.
² Internal Medicine Department, Lariboisière Hospital, Paris, France.
³ Clinic of Infectious Diseases, University of Modena and Reggio Emilia, Modena, Italy.
⁴ Infectious Diseases Unit, Internal Medicine Service, Hospital La Paz, IdiPAZ, Madrid, Spain.
⁵ Department for Clinical Immunology and Rheumatology, Hannover Medical School, Hannover, Germany.
⁶ Toronto General Hospital Research Institute, Toronto, ON, Canada.
⁷ Chelsea and Westminster Hospital NHS Foundation Trust and London School of Hygiene & Tropical Medicine, London, UK.
⁸ Department of Infectious Diseases, Hotel-Dieu Hospital and INSERM CIC 1413, Nantes University Hospital, Nantes 44093, France. Electronic address: francois.raffi@wanadoo.fr.

No abstract available

References

1. Qin C, Zhou L, Hu Z. Dysregulation of immune response in patients with COVID-19 in Wuhan, China. Clin Infect Dis. 2020 doi: 10.1093/cid/ciaa248. published online March 12. - DOI - PMC - PubMed
1. Xu Z, Shi L, Wang Y. Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir Med. 2020;8:420–422. - PMC - PubMed
1. Channappanavar R, Perlman S. Pathogenic human coronavirus infections cause and consequences of cytokine storm and immunopathology. Semin Immunopathol. 2017;39:529–539. - PMC - PubMed
1. Mehta P, McAuley DF, Brown M. COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet. 2020;395:1033–1034. - PMC - PubMed
1. WHO Clinical management of severe acute respiratory infection when novel coronavirus (2019-nCoV) infection is suspected: interim guidance. 28 January 2020. https://apps.who.int/iris/handle/10665/330893